<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: <z:chebi fb="3" ids="41774">Tamoxifen</z:chebi> is a selective <z:chebi fb="67" ids="50114">oestrogen</z:chebi> receptor modulator widely used in the prevention and treatment of <z:hpo ids='HP_0003002'>breast cancer</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Women receiving long-term <z:chebi fb="3" ids="41774">tamoxifen</z:chebi> therapy do not experience <z:hpo ids='HP_0011675'>cardiac arrhythmias</z:hpo> although <z:hpo ids='HP_0011009'>acute</z:hpo> perfusion of <z:chebi fb="3" ids="41774">tamoxifen</z:chebi> has been shown to inhibit cardiac <z:chebi fb="0" ids="29103">K(+)</z:chebi> currents </plain></SENT>
<SENT sid="2" pm="."><plain>This observation suggests that <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:chebi fb="3" ids="41774">tamoxifen</z:chebi> treatment does not negatively modulate cardiac <z:chebi fb="0" ids="29103">K(+)</z:chebi> currents </plain></SENT>
<SENT sid="3" pm="."><plain>Therefore, we investigated the <z:hpo ids='HP_0011010'>chronic</z:hpo> effects of <z:chebi fb="3" ids="41774">tamoxifen</z:chebi> on <z:chebi fb="0" ids="29103">K(+)</z:chebi> currents and channels in mouse and guinea pig ventricles </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS AND RESULTS: Female mice and guinea pigs were treated with placebo or <z:chebi fb="3" ids="41774">tamoxifen</z:chebi> pellets for 60 days </plain></SENT>
<SENT sid="5" pm="."><plain>Voltage-clamp experiments showed that the density of the CaÂ²(+)-independent transient outward (I(to)), the ultrarapid delayed rectifier (I(Kur)), the steady-state (I(ss)), and the inward rectifier (I(K1)) <z:chebi fb="0" ids="29103">K(+)</z:chebi> currents were increased in <z:chebi fb="3" ids="41774">tamoxifen</z:chebi>-treated mice ventricle </plain></SENT>
<SENT sid="6" pm="."><plain>Western blot analysis revealed that protein expression of the underlying <z:chebi fb="0" ids="29103">K(+)</z:chebi> channels Kv4.3 (I(to)), Kv1.5 (I(Kur)), Kv2.1 (I(ss)), and Kir2.1 (I(K1)) were significantly higher in the ventricle of <z:chebi fb="3" ids="41774">tamoxifen</z:chebi>-treated mice </plain></SENT>
<SENT sid="7" pm="."><plain>Protein expression of the <z:chebi fb="0" ids="29103">K(+)</z:chebi> channel subunits encoding I(Kr) and I(Ks) (ERG1, KCNQ1, and KCNE1) was also increased in <z:chebi fb="3" ids="41774">tamoxifen</z:chebi>-treated guinea pig ventricle </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: Conditions with high <z:chebi fb="67" ids="50114">oestrogen</z:chebi> levels are associated with reduced <z:chebi fb="0" ids="29103">K(+)</z:chebi> currents </plain></SENT>
<SENT sid="9" pm="."><plain>Thus, conceivably, <z:chebi fb="3" ids="41774">tamoxifen</z:chebi> might prevent the inhibitory effects of <z:chebi fb="67" ids="50114">oestrogen</z:chebi> on <z:chebi fb="0" ids="29103">K(+)</z:chebi> channels by blocking the <z:chebi fb="67" ids="50114">oestrogen</z:chebi> receptors, which would explain the reported increase in <z:chebi fb="0" ids="29103">K(+)</z:chebi> currents </plain></SENT>
<SENT sid="10" pm="."><plain>These findings could contribute to explain the absence of <z:hpo ids='HP_0011675'>cardiac arrhythmia</z:hpo> with long-term <z:chebi fb="3" ids="41774">tamoxifen</z:chebi> therapy </plain></SENT>
</text></document>